Rothschild & CO Asset Management Us Inc. Puma Biotechnology, Inc. Transaction History

Rothschild & CO Asset Management Us Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 25, 2019	SELL	$12.3 - $35.76 $231,584 - $673,289	-18,828 Closed	0 $0
Q1 2019 May 08, 2019	SELL	$20.77 - $42.37 $343,785 - $701,308	-16,552 Reduced 46.78%	18,828 $730,000
Q4 2018 Feb 05, 2019	BUY	$20.07 - $46.7 $2,267 - $5,277	113 Added 0.32%	35,380 $720,000
Q3 2018 Nov 13, 2018	BUY	$41.2 - $59.85 $160,474 - $233,115	3,895 Added 12.42%	35,267 $1.62 Million
Q2 2018 Aug 07, 2018	BUY	$48.3 - $68.25 $183,298 - $259,008	3,795 Added 13.76%	31,372 $1.86 Million
Q1 2018 May 08, 2018	SELL	$59.7 - $99.25 $190,383 - $316,508	-3,189 Reduced 10.37%	27,577 $1.88 Million
Q4 2017 Feb 12, 2018	SELL	$93.85 - $132.45 $204,217 - $288,211	-2,176 Reduced 6.61%	30,766 $3.04 Million
Q3 2017 Nov 08, 2017	BUY	$72.0 - $119.75 $2.37 Million - $3.94 Million	32,942	32,942 $3.95 Million

100

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $110M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.